[go: up one dir, main page]

FI20040255A7 - Method for detecting the risk of pre-eclampsia - Google Patents

Method for detecting the risk of pre-eclampsia Download PDF

Info

Publication number
FI20040255A7
FI20040255A7 FI20040255A FI20040255A FI20040255A7 FI 20040255 A7 FI20040255 A7 FI 20040255A7 FI 20040255 A FI20040255 A FI 20040255A FI 20040255 A FI20040255 A FI 20040255A FI 20040255 A7 FI20040255 A7 FI 20040255A7
Authority
FI
Finland
Prior art keywords
eclampsia
detecting
risk
subject
biological sample
Prior art date
Application number
FI20040255A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI20040255L (en
FI20040255A0 (en
Inventor
Jukka Salonen
Mia Pirskanen
Tomi-Pekka Tuomainen
Pekka Uimari
Seppo Heinonen
Original Assignee
Oy Jurilab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oy Jurilab Ltd filed Critical Oy Jurilab Ltd
Priority to FI20040255A priority Critical patent/FI20040255A7/en
Publication of FI20040255A0 publication Critical patent/FI20040255A0/en
Priority to PCT/FI2005/050037 priority patent/WO2005078128A1/en
Publication of FI20040255L publication Critical patent/FI20040255L/en
Publication of FI20040255A7 publication Critical patent/FI20040255A7/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Keksintö antaa käyttöön menetelmän ja testipakkauksen kohteen pre-eklampsian riskin tai alttiuden havainnoimiseksi tai diagnosoimiseksi menetelmän käsittäessä vaiheet, joissa annetaan käyttöön testattavalta kohteelta otettu biologinen näyte ja havainnoidaan DDAH-geenin genotyyppimuunnoksen läsnäolo tai poissaolo biologisessa näytteessä. Keksintö antaa myös käyttöön testipakkauksen, joka käsittää välineet keksinnön mukaisen menetelmän toteuttamiseksi, ja menetelmän pre-eklampsian hoitamiseksi tai ehkäisemiseksi.The invention provides a method and a test kit for detecting or diagnosing a subject's risk or susceptibility to pre-eclampsia, the method comprising the steps of providing a biological sample taken from the subject to be tested and detecting the presence or absence of a genotypic variation of the DDAH gene in the biological sample. The invention also provides a test kit comprising means for carrying out the method according to the invention, and a method for treating or preventing pre-eclampsia.

FI20040255A 2004-02-18 2004-02-18 Method for detecting the risk of pre-eclampsia FI20040255A7 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI20040255A FI20040255A7 (en) 2004-02-18 2004-02-18 Method for detecting the risk of pre-eclampsia
PCT/FI2005/050037 WO2005078128A1 (en) 2004-02-18 2005-02-17 Method for detecting the risk of preeclampsia by analysing a dimethylarginine dimethylaminohydrolase gene

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20040255A FI20040255A7 (en) 2004-02-18 2004-02-18 Method for detecting the risk of pre-eclampsia

Publications (3)

Publication Number Publication Date
FI20040255A0 FI20040255A0 (en) 2004-02-18
FI20040255L FI20040255L (en) 2005-08-19
FI20040255A7 true FI20040255A7 (en) 2005-08-19

Family

ID=31725731

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20040255A FI20040255A7 (en) 2004-02-18 2004-02-18 Method for detecting the risk of pre-eclampsia

Country Status (2)

Country Link
FI (1) FI20040255A7 (en)
WO (1) WO2005078128A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105939647B (en) 2013-10-24 2020-01-21 奥瑞斯健康公司 Robot-assisted endovascular surgery system and related methods
CN106755492B (en) * 2017-01-24 2020-04-21 深圳金蕊科技有限公司 Complete set of SNP (Single nucleotide polymorphism) for predicting preeclampsia and application thereof
EP3600031A4 (en) 2017-03-31 2021-01-20 Auris Health, Inc. ROBOTIC SYSTEMS FOR NAVIGATION OF LUMINAL NETWORKS THAT COMPENSATE FOR PHYSIOLOGICAL NOISE
US10022192B1 (en) 2017-06-23 2018-07-17 Auris Health, Inc. Automatically-initialized robotic systems for navigation of luminal networks
US10426559B2 (en) 2017-06-30 2019-10-01 Auris Health, Inc. Systems and methods for medical instrument compression compensation
CN110831536B (en) 2017-12-06 2021-09-07 奥瑞斯健康公司 System and method for correcting for uncommanded instrument roll
JP7451686B2 (en) 2019-08-30 2024-03-18 オーリス ヘルス インコーポレイテッド Instrument image reliability system and method
CN114901194B (en) 2019-12-31 2024-08-30 奥瑞斯健康公司 Anatomical feature identification and targeting
EP4084722A4 (en) 2019-12-31 2024-01-10 Auris Health, Inc. ALIGNMENT INTERFACES FOR PERCUTANEOUS ACCESS
KR20220123076A (en) 2019-12-31 2022-09-05 아우리스 헬스, 인코포레이티드 Alignment Techniques for Transdermal Access
US11737663B2 (en) 2020-03-30 2023-08-29 Auris Health, Inc. Target anatomical feature localization
CN113223714B (en) * 2021-05-11 2022-07-05 吉林大学 A gene combination for predicting preeclampsia risk, preeclampsia risk prediction model and construction method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006514531A (en) * 2001-02-16 2006-05-11 インサイト・ゲノミックス・インコーポレイテッド Drug metabolizing enzymes
US20040214264A1 (en) * 2002-04-19 2004-10-28 Veli-Pekka Valkonen Nucleic acid molecule encoding a variant DDAH 1 protein and uses thereof
FI115532B (en) * 2002-10-07 2005-05-31 Jurilab Ltd Oy Procedure for detecting the risk of cardiovascular disease

Also Published As

Publication number Publication date
FI20040255L (en) 2005-08-19
WO2005078128A1 (en) 2005-08-25
FI20040255A0 (en) 2004-02-18

Similar Documents

Publication Publication Date Title
ATE428929T1 (en) REAGENT, EQUIPMENT AND METHOD FOR SAMPLE ANALYSIS
WO2004055519A3 (en) Specific markers for pancreatic cancer
DE60041839D1 (en) Auto-antibodies against annexin proteins as a marker of lung cancer
WO2007103374A3 (en) Toxicity screening methods
FI20050011A7 (en) Method and test kit for detecting the risk of type 2 diabetes mellitus
DE602004030054D1 (en) Apparatus for testing biological samples and chemical samples
DE60223561D1 (en) METHOD FOR DETECTING OXIDATIVE STRESS AND KIT FOR IMPLEMENTING THEREOF
WO2007136724A3 (en) Method for automated tissue analysis
FI20040255A7 (en) Method for detecting the risk of pre-eclampsia
DE60228557D1 (en) CANDIDA-PROOF
ATE514792T1 (en) ELITE EVENT A5547-127 AND METHODS AND KITS FOR IDENTIFYING SUCH EVENT IN BIOLOGICAL SAMPLES
ATE452343T1 (en) IMPROVED VITAMIN D MEASUREMENT
ATE408829T1 (en) METHODS AND ASSAY KITS FOR DETECTING MONONUCLEAR CELL PHENOTYPES
ATE474228T1 (en) REAGENT FOR HEMOGLOBINA DEGRADATION
DE602006011917D1 (en) METHOD AND SUBSTANCES FOR ISOLATING MIRNAS
EP2212700B8 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
DE60315715D1 (en) USE OF NICOTINAMIDE N-METHYLTRANSFERASE FOR THE DIAGNOSIS OF COLORECTAL CANCER
ATE503846T1 (en) METHOD FOR DIAGNOSIS OF OVARIAL CARCINOMA
WO2005054516A3 (en) Peptide nucleic acid probes for analysis of certain staphylococcus species
ATE557101T1 (en) METHODS AND COMPOSITIONS FOR DETERMINING A TRANSPLANTATION TOLERANT PHENOTYPE IN AN INDIVIDUAL
ATE514948T1 (en) IN VITRO METHOD FOR DIAGNOSING NEURODEGENERATIVE DISEASES
NZ551782A (en) Agents and methods for diagnosing stress
DE602004017317D1 (en) USE OF THE PROTEINS PROTEINASE 3 (PRN3) AND LEUKOCYTES ELASTATES INHIBITOR (ILEU) AS A MARKER FOR COLORECTAL CARCINOMAS
ATE504833T1 (en) METHOD FOR DETERMINING THE PHENOTYPE OF CELLS
ATE475098T1 (en) METHOD FOR MEASURING PLASMA LEVELS OF PENTRAXIN PTX3

Legal Events

Date Code Title Description
FD Application lapsed